Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2026-05-19 @ 8:49 AM
Study NCT ID:
NCT01187303
Status:
COMPLETED
Last Update Posted:
2015-11-02
First Post:
2010-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)
Sponsor:
University of Cologne
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsed NLPHL | View |
Keywords: